230 related articles for article (PubMed ID: 32933245)
1. Influenza A M2 Inhibitor Binding Understood through Mechanisms of Excess Proton Stabilization and Channel Dynamics.
Watkins LC; DeGrado WF; Voth GA
J Am Chem Soc; 2020 Oct; 142(41):17425-17433. PubMed ID: 32933245
[TBL] [Abstract][Full Text] [Related]
2. X-ray Crystal Structures of the Influenza M2 Proton Channel Drug-Resistant V27A Mutant Bound to a Spiro-Adamantyl Amine Inhibitor Reveal the Mechanism of Adamantane Resistance.
Thomaston JL; Konstantinidi A; Liu L; Lambrinidis G; Tan J; Caffrey M; Wang J; Degrado WF; Kolocouris A
Biochemistry; 2020 Feb; 59(4):627-634. PubMed ID: 31894969
[TBL] [Abstract][Full Text] [Related]
3. Designing inhibitors of M2 proton channel against H1N1 swine influenza virus.
Du QS; Huang RB; Wang SQ; Chou KC
PLoS One; 2010 Feb; 5(2):e9388. PubMed ID: 20186344
[TBL] [Abstract][Full Text] [Related]
4. Proton-Induced Conformational and Hydration Dynamics in the Influenza A M2 Channel.
Watkins LC; Liang R; Swanson JMJ; DeGrado WF; Voth GA
J Am Chem Soc; 2019 Jul; 141(29):11667-11676. PubMed ID: 31264413
[TBL] [Abstract][Full Text] [Related]
5. Multiscale Simulation of an Influenza A M2 Channel Mutant Reveals Key Features of Its Markedly Different Proton Transport Behavior.
Watkins LC; DeGrado WF; Voth GA
J Am Chem Soc; 2022 Jan; 144(2):769-776. PubMed ID: 34985907
[TBL] [Abstract][Full Text] [Related]
6. Design of Broad-Spectrum Inhibitors of Influenza A Virus M2 Proton Channels: A Molecular Modeling Approach.
Klimochkin YN; Shiryaev VA; Petrov PV; Radchenko EV; Palyulin VA; Zefirov NS
Curr Comput Aided Drug Des; 2016; 12(2):154-64. PubMed ID: 27146707
[TBL] [Abstract][Full Text] [Related]
7. Viral M2 ion channel protein: a promising target for anti-influenza drug discovery.
Moorthy NS; Poongavanam V; Pratheepa V
Mini Rev Med Chem; 2014; 14(10):819-30. PubMed ID: 25342196
[TBL] [Abstract][Full Text] [Related]
8. An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses.
Hu Y; Musharrafieh R; Ma C; Zhang J; Smee DF; DeGrado WF; Wang J
Antiviral Res; 2017 Apr; 140():45-54. PubMed ID: 28087313
[TBL] [Abstract][Full Text] [Related]
9. Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus.
Wang J; Wu Y; Ma C; Fiorin G; Wang J; Pinto LH; Lamb RA; Klein ML; Degrado WF
Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1315-20. PubMed ID: 23302696
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of the M2 Proton Channel Engage and Disrupt Transmembrane Networks of Hydrogen-Bonded Waters.
Thomaston JL; Polizzi NF; Konstantinidi A; Wang J; Kolocouris A; DeGrado WF
J Am Chem Soc; 2018 Nov; 140(45):15219-15226. PubMed ID: 30165017
[TBL] [Abstract][Full Text] [Related]
11. Structural and energetic analysis of drug inhibition of the influenza A M2 proton channel.
Gu RX; Liu LA; Wei DQ
Trends Pharmacol Sci; 2013 Oct; 34(10):571-80. PubMed ID: 24011996
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in computational studies on influenza a virus M2 proton channel.
Wang JF; Chou KC
Mini Rev Med Chem; 2012 Sep; 12(10):971-8. PubMed ID: 22420575
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of the drug-resistant S31N influenza M2 proton channel.
Thomaston JL; DeGrado WF
Protein Sci; 2016 Aug; 25(8):1551-4. PubMed ID: 27082171
[TBL] [Abstract][Full Text] [Related]
14. The L46P mutant confers a novel allosteric mechanism of resistance toward the influenza A virus M2 S31N proton channel blockers.
Musharrafieh R; Lagarias PI; Ma C; Tan GS; Kolocouris A; Wang J
Mol Pharmacol; 2019 Aug; 96(2):148-157. PubMed ID: 31175183
[TBL] [Abstract][Full Text] [Related]
15. Analysis by metadynamics simulation of binding pathway of influenza virus M2 channel blockers.
Sakai Y; Kawaguchi A; Nagata K; Hirokawa T
Microbiol Immunol; 2018 Jan; 62(1):34-43. PubMed ID: 29210473
[TBL] [Abstract][Full Text] [Related]
16. Why bound amantadine fails to inhibit proton conductance according to simulations of the drug-resistant influenza A M2 (S31N).
Gleed ML; Busath DD
J Phys Chem B; 2015 Jan; 119(3):1225-31. PubMed ID: 25426702
[TBL] [Abstract][Full Text] [Related]
17. A secondary gate as a mechanism for inhibition of the M2 proton channel by amantadine.
Yi M; Cross TA; Zhou HX
J Phys Chem B; 2008 Jul; 112(27):7977-9. PubMed ID: 18476738
[TBL] [Abstract][Full Text] [Related]
18. Protein structural defects enable pharmaceutical targeting while functionalizing the M2 proton channel.
Fernández A
Biochem Biophys Res Commun; 2019 Jun; 514(1):86-91. PubMed ID: 31023526
[TBL] [Abstract][Full Text] [Related]
19. High-resolution structures of the M2 channel from influenza A virus reveal dynamic pathways for proton stabilization and transduction.
Thomaston JL; Alfonso-Prieto M; Woldeyes RA; Fraser JS; Klein ML; Fiorin G; DeGrado WF
Proc Natl Acad Sci U S A; 2015 Nov; 112(46):14260-5. PubMed ID: 26578770
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of drug inhibition and drug resistance of influenza A M2 channel.
Pielak RM; Schnell JR; Chou JJ
Proc Natl Acad Sci U S A; 2009 May; 106(18):7379-84. PubMed ID: 19383794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
